Dr Sue Chua is a Multimodality Imaging Consultant with dual accreditation in radiology and nuclear medicine. A University of Sydney graduate, she trained in radiology in Nottingham (2001-05) and Nuclear Medicine and PET/CT in Nottingham, the Institute of Nuclear Medicine (UCLH), and the Oklahoma Heart Hospital, USA.

Dr Chua was appointed to The Royal Marsden in 2008 with a remit to support and develop PET/CT research activity. Her research interests are principally in multimodality functional imaging, in particular PET/CT and functional CT and MRI imaging. Her clinical areas of interest include urology, paediatric oncology, lymphoma, upper and lower GI malignancies, lung and neuro-oncology.

1 Radiotherapy planning in oncology: science and practice

Part I PET/CT in radiotherapy planning

2 Instrumentation

3 Patient preparation and setup

4 Data acquisition, reconstruction and transfer

5 Sources of artifacts: consequences and solutions.

7 4D-PET/CT respiratory gated acquisition techniques

Part II PET/CT in radiotherapy planning: current evidence

8 Lung cancer

9 Head and neck Cancers

10 Gastrointestinal Malignancies

11 Prostate cancer

12 Gynaecological Cancers

13 Paediatric Cancers

This pocket book offers a succinct but comprehensive overview of the role of PET/CT in radiotherapy planning. Individual chapters are devoted to specific application of the technique to particular tumor types, including non-small cell lung, gastrointestinal, head and neck squamous cell, prostate, gynecological, and pediatric tumors. Helpful information is also presented on the practical implementation of PET/CT in routine oncological practice. Technical and logistical issues are discussed, and guidance provided on potential problems and pitfalls and available solutions. The book will be invaluable in assisting readers to exploit PET/CT's ability to significantly improve delineation of tumor tissue through the addition of metabolic information to structural imaging data, thereby avoiding unnecessary radiation injury and associated complications while enhancing therapeutic effects and minimizing the risk of marginal recurrences. It is published within the Springer series Clinicians' Guides to Radionuclide Hybrid Imaging, compiled under the auspices of the British Nuclear Medicine Society.